Your browser doesn't support javascript.
loading
Corrigendum to "DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer" [Canc. Lett. 501 224-233].
Moskovich, Dotan; Alfandari, Adi; Finkelshtein, Yael; Weisz, Avivit; Katzav, Aviva; Kidron, Debora; Edelstein, Evgeny; Veroslavski, Daniel; Perets, Ruth; Arbib, Nissim; Kadan, Yfat; Fishman, Ami; Lerer, Bernard; Ellis, Martin; Ashur-Fabian, Osnat.
Afiliação
  • Moskovich D; Translational Oncology Laboratory, Hematology Institute and Blood Bank, Meir Medical Center, Kfar-Saba, Israel; Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Alfandari A; Translational Oncology Laboratory, Hematology Institute and Blood Bank, Meir Medical Center, Kfar-Saba, Israel; Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Finkelshtein Y; Translational Oncology Laboratory, Hematology Institute and Blood Bank, Meir Medical Center, Kfar-Saba, Israel; Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Weisz A; Department of Pathology, Meir Medical Center, Kfar Saba, Israel; Sackler Faculty of Medicine, Israel.
  • Katzav A; Department of Pathology, Meir Medical Center, Kfar Saba, Israel; Sackler Faculty of Medicine, Israel.
  • Kidron D; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Pathology, Meir Medical Center, Kfar Saba, Israel; Sackler Faculty of Medicine, Israel.
  • Edelstein E; Department of Pathology, Meir Medical Center, Kfar Saba, Israel; Sackler Faculty of Medicine, Israel.
  • Veroslavski D; Clinical Research Institute at Rambam, Division of Oncology, Rambam Health Care Campus, Technion-Israel Institute of Technology, Haifa, Israel.
  • Perets R; Clinical Research Institute at Rambam, Division of Oncology, Rambam Health Care Campus, Technion-Israel Institute of Technology, Haifa, Israel.
  • Arbib N; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; Gynecological Oncology Unit, The Department of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba, Israel.
  • Kadan Y; Gynecological Oncology Unit, The Department of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba, Israel.
  • Fishman A; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; Gynecological Oncology Unit, The Department of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba, Israel.
  • Lerer B; Biological Psychiatry Laboratory Hadassah - Hebrew University Medical Center, Jerusalem, Israel.
  • Ellis M; Translational Oncology Laboratory, Hematology Institute and Blood Bank, Meir Medical Center, Kfar-Saba, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Ashur-Fabian O; Translational Oncology Laboratory, Hematology Institute and Blood Bank, Meir Medical Center, Kfar-Saba, Israel; Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: osnataf@gmail.com.
Cancer Lett ; 563: 216196, 2023 Jun 01.
Article em En | MEDLINE | ID: mdl-37104919
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Cancer Lett Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Israel
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Cancer Lett Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Israel